KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Repligen (RGEN) over the last 15 years, with Q3 2025 value amounting to $2.9 billion.

  • Repligen's Liabilities and Shareholders Equity rose 328.78% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 billion, marking a year-over-year increase of 110.37%. This contributed to the annual value of $2.8 billion for FY2024, which is 5.37% down from last year.
  • Latest data reveals that Repligen reported Liabilities and Shareholders Equity of $2.9 billion as of Q3 2025, which was up 328.78% from $2.9 billion recorded in Q2 2025.
  • In the past 5 years, Repligen's Liabilities and Shareholders Equity ranged from a high of $2.9 billion in Q3 2025 and a low of $1.9 billion during Q1 2021
  • Over the past 5 years, Repligen's median Liabilities and Shareholders Equity value was $2.5 billion (recorded in 2023), while the average stood at $2.6 billion.
  • In the last 5 years, Repligen's Liabilities and Shareholders Equity skyrocketed by 5182.37% in 2021 and then fell by 5.43% in 2025.
  • Quarter analysis of 5 years shows Repligen's Liabilities and Shareholders Equity stood at $2.4 billion in 2021, then increased by 7.35% to $2.5 billion in 2022, then grew by 11.83% to $2.8 billion in 2023, then dropped by 0.05% to $2.8 billion in 2024, then grew by 3.32% to $2.9 billion in 2025.
  • Its Liabilities and Shareholders Equity was $2.9 billion in Q3 2025, compared to $2.9 billion in Q2 2025 and $2.9 billion in Q1 2025.